Stay Informed
of New Reports
Twitter
Where To Report Waste
Fraud, Abuse, Or Retaliation
Where To Report Waste Fraud, Abuse, Or Retaliation
Recommendation Details
Text of Recommendation
Rec. 1: The DoD OIG recommended that the Director of the Defense Health Agency ensure that DoD medical treatment facilities and the Navy Bureau of Medicine and Surgery revise their guidance to limit Schedule II amphetamines prescriptions used to treat attention-deficit hyperactivity disorder to no more than a 90-day supply, except for applicable deployments.
Recommendation Number
D-2021-0073-D000AW-0001-0001
Recommendation Status
Open
Significant Recommendation
No
Recommendation Questioned Costs
$0
Recommendation Funds for Better Use
$0
Associated Report Details
Submitting OIG
Department of Defense OIG
Linked Report
Audit of Compliance With Defense Health Agency Guidance on the Number of Days Supply of Schedule II Amphetamine Prescriptions Dispensed by Department of Defense Medical Treatment Facilities